BeatO
PrivateLast Round
Series B
Nov 16, 2022
Est. Valuation
$34.4M
Total Funding Raised
$56.2M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
BeatO is a health technology company that provides a digital care platform for managing chronic conditions, offering smartphone-connected glucometers and an application for tracking, insights, and access to healthcare professionals.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Telemedicine, Health IoT, D2C Brands, Subscription Commerce
Business Model
B2C
Customer Profile
Hardware + Subscription, Hardware Sales, Subscription SaaS, Marketplace Commission
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BeatO Comparables
Compare BeatO with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| sugar.fit | 84% | |
| Breathe Well-being | 80% | |
| Fitterfly | 78% |
BeatO Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Nov 16, 2022 | ||||
| Debt | Sep 10, 2022 | ||||
| Debt | Apr 27, 2022 | ||||
| Series A Extension | Jul 7, 2021 | ||||
| Series A | Jun 1, 2021 | ||||
Pre Seed | Mar 20, 2019 |
Key People
Founding team and executive leadership
BeatO Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Alteria Capital | Debt |
| Leo Capital | Series A Extension, Series A, Pre Seed, Series B, Seed |
| Sage Hill Investors | Debt |
| Orios Venture Partners | Series A Extension, Series A, Series B, Pre Seed |
| Blume Ventures | Series A Extension, Series A, Pre Seed, Series B, Seed |
| W Health Ventures | Series B, Debt, Series A Extension |
| Merisis Advisors | Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 39% MoM to 223.2K.
- Nov 16, 2022
$33M round led by Lightrock and Lightrock India.
BeatO Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about BeatO's valuation, stock price, and market status.
Is BeatO a public or private company?
BeatO is a private company.
What is the current stock price of BeatO?
BeatO is a private company, so its shares have no public market price. Caplight tracks BeatO's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is BeatO worth (valuation)?
BeatO's valuation is estimated at $34.4M based on funding round data.
Can I buy BeatO stock?
BeatO shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was BeatO's last funding round?
BeatO's most recent funding round was Series B on November 16, 2022.
Who are the main investors in BeatO?
Key investors in BeatO include Alteria Capital, Leo Capital, Orios Venture Partners, Blume Ventures, W Health Ventures.
Will BeatO IPO soon?
No public IPO plans have been announced for BeatO.
How can I track BeatO secondary market activity?
Caplight tracks bids, offers, and trades in BeatO's shares on secondary markets.